Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 1 |
2000 | 1 |
2010 | 3 |
2015 | 1 |
2016 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.
Cephalalgia. 2010.
PMID: 20647171
Clinical Trial.
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group.
Aurora SK, et al.
Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.
Cephalalgia. 2010.
PMID: 20647170
Clinical Trial.
Item in Clipboard
Pregnancy outcomes following exposure to onabotulinumtoxinA.
Brin MF, Kirby RS, Slavotinek A, Miller-Messana MA, Parker L, Yushmanova I, Yang H.
Brin MF, et al. Among authors: miller messana ma.
Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):179-87. doi: 10.1002/pds.3920. Epub 2015 Dec 4.
Pharmacoepidemiol Drug Saf. 2016.
PMID: 26635276
Free PMC article.
Item in Clipboard
Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications.
Naumann M, Carruthers A, Carruthers J, Aurora SK, Zafonte R, Abu-Shakra S, Boodhoo T, Miller-Messana MA, Demos G, James L, Beddingfield F, VanDenburgh A, Chapman MA, Brin MF.
Naumann M, et al. Among authors: miller messana ma.
Mov Disord. 2010 Oct 15;25(13):2211-8. doi: 10.1002/mds.23254.
Mov Disord. 2010.
PMID: 20737546
Item in Clipboard
Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy.
Johnston E, Crawford J, Blackwell S, Bjurstrom T, Lockbaum P, Roskos L, Yang BB, Gardner S, Miller-Messana MA, Shoemaker D, Garst J, Schwab G.
Johnston E, et al. Among authors: miller messana ma.
J Clin Oncol. 2000 Jul;18(13):2522-8. doi: 10.1200/JCO.2000.18.13.2522.
J Clin Oncol. 2000.
PMID: 10893282
Clinical Trial.
Item in Clipboard
A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans.
Molineux G, Kinstler O, Briddell B, Hartley C, McElroy P, Kerzic P, Sutherland W, Stoney G, Kern B, Fletcher FA, Cohen A, Korach E, Ulich T, McNiece I, Lockbaum P, Miller-Messana MA, Gardner S, Hunt T, Schwab G.
Molineux G, et al. Among authors: miller messana ma.
Exp Hematol. 1999 Dec;27(12):1724-34. doi: 10.1016/s0301-472x(99)00112-5.
Exp Hematol. 1999.
PMID: 10641590
Free article.
Item in Clipboard
Cite
Cite